Idhifa
| Idhifa | |
|---|---|
| Term | Idhifa |
| Short definition | Idhifa (ide-HEE-fuh) A drug used to treat adults with acute myeloid leukemia that has come back or has not improved with other treatments. It is used in patients whose cancer has a mutation (change) in the IDH2 gene. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Idhifa - (pronounced) (ide-HEE-fuh) A drug used to treat adults with acute myeloid leukemia that has come back or has not improved with other treatments. It is used in patients whose cancer has a mutation (change) in the IDH2 gene. It is also being studied in the treatment of other types of cancer. Idhifa blocks the protein IDH2Gen made by the mutant. Blocking this protein can help prevent cancer cells from growing. Idhifa is a type of enzyme inhibitor. Also called enasidenib mesylate
External links
- Medical encyclopedia article on Idhifa
- Wikipedia's article - Idhifa
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski